SEC Says Cannabis Pill Maker Ran $2M Securities Fraud
By Katryna Perera · September 28, 2021, 7:52 PM EDT
The U.S. Securities and Exchange Commission on Tuesday filed suit against the makers of the cannabis pill Idrasil, alleging that C3 International Inc. and its co-founders raised approximately $2 million from...
To view the full article, register now.